Co-create trust. Forge new patient ecosystems.
Our ability to turn great products into great medicines has never been more reliant on how we engage with our patients, yet we’re still falling short of expectations and failing to build sustainable trust with our communities, leading to lower adherence, slower trials and sub-optimal outcomes.
Co-creation must be the lifeblood of your business, spanning product lifecycles from clinical phases to commercial strategy execution. Only then can we start to build sustainable, long-term trust with patient communities. To do this we must go beyond the diagnosis and streamline the patient journey.
Pioneer the patient engagement transformation and maintain competitive advantage at Reuters Events: Pharma & Patient USA 2024. America’s leading patient focused event to help you solve these challenges and optimize opportunities for you and your patients.
2023 speakers
2023’s industry defining themes
- Co-create on instinct: Pioneer a culture of co-creation across your business to build a foundation for trust with your patients
- Collaborate, collaborate, collaborate: Enhance the efficiency of drug development, maximize insights, and drive innovation by uniting stakeholders on shared principles and values, leading to lasting partnerships and improved patient outcomes
- Beyond the patient: Adapt your approach to target your teams on human-led engagement to boost the consumer experience and elevate adherence rates
- Advance health equity and access across the value chain: Implement targeted initiatives to address disparities in healthcare access, improve minority health outcomes, and foster an inclusive, patient-centered ecosystem for lasting positive change
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.